Aiosyn and HistoWiz: Aiosyn’s kidney image analysis tools are now available on HistoWiz’s PathologyMap
Nijmegen, the Netherlands – Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, is thrilled to announce the integration of its NephroPath AI tools into HistoWiz’s PathologyMap™ platform. This collaboration provides researchers using PathologyMap™ with state-of-the-art solutions for kidney tissue analysis, facilitating and accelerating scientific research.
“Our integration with PathologyMap reflects Aiosyn’s commitment to delivering AI solutions that seamlessly integrate with leading platforms that are used by pathologists and researchers worldwide. By enabling efficient, precise, and reproducible analysis of kidney tissue, Aiosyn and HistoWiz are advancing the boundaries of kidney disease research and supporting the discovery of new treatments.”Patrick de Boer, CEO of Aiosyn
Aiosyn’s AI applications are designed to support (pre)clinical studies, delivering tools for analyzing and quantifying renal tissue structures. These tools facilitate the precise identification of pathological changes, improving the understanding of kidney disease progression and treatment efficacy.
PathologyMap™ is a web-based platform that enables researchers to view, manage, analyze, and share their histopathology data seamlessly. The addition of Aiosyn’s NephroPath AI tools allows for one-click analysis, streamlining workflows, and improving the precision and reproducibility of renal assessments.
“By integrating Aiosyn’s AI tools into PathologyMap, we are providing our users with state-of-the-art resources to enhance their research capabilities,” said Linh Hoang, CEO of HistoWiz. “This collaboration underscores our commitment to advancing digital pathology and supporting the scientific community with innovative solutions.”
For more information about PathologyMap™ and the integration of NephroPath AI tools, visit the HistoWiz‘s AI Apps Library. To request a demonstration of NephroPath’s technology, contact Aiosyn at contact@aiosyn.com.
Figure 1. Healthy glomeruli in mouse kidneys are automatically identified and highlighted by NephroPath’s AI algorithms.
About Aiosyn
Based in the Netherlands, Aiosyn develops precision pathology software for breast cancer and kidney disease, integrating its solutions into standard pathology workflows. Aiosyn has been built upon more than 20 years of research experience in the field of pathology and is rooted in pathology practice.
About HistoWiz
HistoWiz accelerates scientific discoveries by automating histology and digital pathology solutions. The company processes tissue specimens for GLP and non-GLP studies, digitizing data onto its web-based platform, PathologyMap™, for streamlined review and analysis. With a network of over 130 board-certified pathologists available for on-demand consultation, HistoWiz combines automation, AI, and global collaboration to advance the scientific understanding of biology.
SOURCE: Aiosyn
